Skip to main content
JEIL PHARMACEUTICAL CO.,LTD logo

JEIL PHARMACEUTICAL CO.,LTD — Investor Relations & Filings

Ticker · 271980 ISIN · KR7271980005 KO Manufacturing
Open in API
Filings indexed 135 across all filing types
Latest filing 2020-05-07 Capital/Financing Update
Country KR South Korea
Listing KO 271980

About JEIL PHARMACEUTICAL CO.,LTD

https://www.jeilpharm.co.kr/english/

JEIL PHARMACEUTICAL CO.,LTD. is a company engaged in the development, manufacturing, and distribution of pharmaceutical products. Its portfolio includes both finished drug products and Active Pharmaceutical Ingredients (APIs). The company produces a diverse range of dosage forms, such as solid medicines (tablets and capsules), patches, and injections, with a strategic focus on becoming a leading manufacturer of injection-based medicines. Committed to developing high-value products, the company operates KGMP-certified manufacturing facilities. Research and development activities are central to its operations, driven by its dedicated R&D center.

Recent filings

Filing Released Lang Actions
기타경영사항(자율공시)
Capital/Financing Update Classification · 95% confidence The document is a voluntary disclosure (자율공시) from Jeil Pharmaceutical regarding the establishment of a 100% owned subsidiary, Onconic Therapeutics. It details the investment amount, purpose, and board decision date. Since it does not fit into specific categories like M&A (which usually involves external entities) or capital changes (share issuance), and is a general regulatory disclosure of a corporate event, it falls under the RNS (Regulatory Filings) category.
2020-05-07 Korean
사업보고서 (2019.12)
Annual Report Classification · 100% confidence The document is a comprehensive 'Business Report' (사업보고서) for Jeil Pharmaceutical Co., Ltd. for the fiscal year 2019 (Jan 1, 2019 to Dec 31, 2019). It contains detailed financial statements, management analysis, board information, and operational data, which corresponds to the standard 10-K annual report filing in the Korean regulatory system. FY 2019
2020-03-30 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment or dismissal of an outside director (사외이사의 선임ㆍ해임). This falls under the category of changes to the board of directors or senior management.
2020-03-25 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a regulatory filing from Jeil Pharmaceutical Co., Ltd. titled 'Report on the Appointment, Dismissal, or Resignation of Outside Directors'. This document specifically details changes to the company's board composition, which falls under the category of Board/Management Information.
2020-03-25 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). It details the appointment of a new outside director for Jeil Pharmaceutical Co., Ltd. following their general meeting. This falls under the category of board management changes.
2020-03-25 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the resignation of an outside director (사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고). This falls under the category of changes in the company's board of directors or senior management.
2020-03-25 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.